Cognitive problems are common in people with Multiple Sclerosis (MS), and researchers and clinicians have used a vast array of measures to assess cognition. Our aim was to systematically identify cognitive measures routinely used in MS research, and outline their different uses. Previous recommendations of cognitive measures to use in MS have relied on expert consensus approaches. We believe this systematic review is a starting point for an evidence-based approach to recommend cognitive tests for use with people with MS. We systematically searched electronic databases using relevant search terms for studies that assessed cognitive functioning in MS (last search in February 2020). From 11,854 abstracts retrieved, based on title and abstract ...
Publisher Copyright: © 2015 by Liga Mekša.Cognitive changes are common in people with multiple scler...
Cognitive impairment is an important contributor to disability in multiple sclerosis (MS), one of th...
Aim: to identify the degree of cognitive impairment (CN) and to optimize the treatment of patients w...
Cognitive problems are common in people with Multiple Sclerosis (MS), and researchers and clinicians...
IntroductionThe Multiple Sclerosis Screening Questionnaire (MSNQ) is a self-report measure used to a...
Background It is estimated that as many as 86% of people with Multiple Sclerosis (MS) can experienc...
Everyday memory is one of the most affected cognitive functions in Multiple Sclerosis (MS). Assessin...
Introduction: The Multiple Sclerosis Neuropsychological Screening Questionnaire (MSNQ) is a self-rep...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...
Abstract Background Cognitive impairment is a common clinical feature of multiple sclerosis (MS)...
Multiple Sclerosis (MS) is the most common disabling neurological disease affecting young and middl...
Multiple sclerosis; Neurophysiological monitoring; Neuropsychological testsEsclerosi múltiple; Monit...
Cognitive impairment can emerge in the earliest phases of multiple sclerosis. It strongly impacts di...
Background: Cognitive dysfunction appears all through the course of multiple sclerosis (MS). Mild an...
Background: People diagnosed with Multiple Sclerosis often have cognitive problems. However, it is u...
Publisher Copyright: © 2015 by Liga Mekša.Cognitive changes are common in people with multiple scler...
Cognitive impairment is an important contributor to disability in multiple sclerosis (MS), one of th...
Aim: to identify the degree of cognitive impairment (CN) and to optimize the treatment of patients w...
Cognitive problems are common in people with Multiple Sclerosis (MS), and researchers and clinicians...
IntroductionThe Multiple Sclerosis Screening Questionnaire (MSNQ) is a self-report measure used to a...
Background It is estimated that as many as 86% of people with Multiple Sclerosis (MS) can experienc...
Everyday memory is one of the most affected cognitive functions in Multiple Sclerosis (MS). Assessin...
Introduction: The Multiple Sclerosis Neuropsychological Screening Questionnaire (MSNQ) is a self-rep...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...
Abstract Background Cognitive impairment is a common clinical feature of multiple sclerosis (MS)...
Multiple Sclerosis (MS) is the most common disabling neurological disease affecting young and middl...
Multiple sclerosis; Neurophysiological monitoring; Neuropsychological testsEsclerosi múltiple; Monit...
Cognitive impairment can emerge in the earliest phases of multiple sclerosis. It strongly impacts di...
Background: Cognitive dysfunction appears all through the course of multiple sclerosis (MS). Mild an...
Background: People diagnosed with Multiple Sclerosis often have cognitive problems. However, it is u...
Publisher Copyright: © 2015 by Liga Mekša.Cognitive changes are common in people with multiple scler...
Cognitive impairment is an important contributor to disability in multiple sclerosis (MS), one of th...
Aim: to identify the degree of cognitive impairment (CN) and to optimize the treatment of patients w...